Dolul
Dolul, also known as dolutegravir, is an antiretroviral medication used to treat HIV/AIDS. It belongs to the class of drugs called integrase strand transfer inhibitors (INSTIs) and works by blocking the HIV virus from integrating its genetic material into the host cell's DNA, thereby preventing the virus from replicating. Dolul is typically used in combination with other antiretroviral drugs to manage HIV infection and reduce the viral load in the body.
The drug was approved by the U.S. Food and Drug Administration (FDA) in 2012 and has since
Dolul is generally well-tolerated, with common side effects including headache, nausea, diarrhea, and fatigue. Serious side
In summary, dolul is a crucial component of modern HIV treatment, offering a once-daily dosing regimen and